Jeffrey L. Cummings
Jeffrey L. Cummings publishes mostly in Psychiatry and Mental health, Physiology and Neurology, on topics such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #30,117 of 7,710,434 ranked researchers
- Rank in United States
- #11,393 of 1,627,098
- Works
- 1,499
- Citations
- 176k
- Citations per work
- 117.1
What does Jeffrey L. Cummings research?
Jeffrey L. Cummings's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (6%), Neuroscience (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else67845.2%
- Health Sciences64242.8%
- Medicine64242.8%
- Life Sciences18012.0%
- 1Psychiatry and Mental health20% of their works
- 2Physiology12% of their works
- 3Neurology7% of their works
- 4Molecular Biology6% of their works
- 5Cognitive Neuroscience6% of their works
- 6Pharmacology4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Parkinson's Disease Mechanisms and Treatments
- Schizophrenia research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Functional Brain Connectivity Studies
- Neurological disorders and treatments
Which keywords describe Jeffrey L. Cummings's research?
The keywords of their largest research topics: Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Neurodegeneration, Oxidative Stress, Amyloid Hypothesis, Tau Pathology and Parkinson's Disease.
- Deep Brain Stimulation
- Functional Connectivity
- Cost-effectiveness Analysis
- Antipsychotic Drugs
- Dopaminergic Neurons
- Acetylcholinesterase
- Parkinson's Disease
- Amyloid Hypothesis
- Neurodegeneration
- Dementia
- Alzheimer's Disease
- Mild Cognitive Impairment
- Oxidative Stress
- Tau Pathology
- Neurological Disorders
- Cholinesterase Inhibitors
- a-Synuclein
- Neurocognitive Deficits
- Quality of Life
- Resting-State fMRI
- Subthalamic Nucleus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Alzheimer's Disease7062 topics
- Dementia5701 topic
- Mild Cognitive Impairment5701 topic
- Neurodegeneration5052 topics
- Oxidative Stress5052 topics
- Amyloid Hypothesis4031 topic
- Tau Pathology4031 topic
- Parkinson's Disease1722 topics
- Neurological Disorders1492 topics
- Acetylcholinesterase1361 topic
- Cholinesterase Inhibitors1361 topic
- Dopaminergic Neurons1021 topic
- a-Synuclein1021 topic
- Antipsychotic Drugs971 topic
- Neurocognitive Deficits971 topic
- Cost-effectiveness Analysis801 topic
- Quality of Life801 topic
- Functional Connectivity791 topic
- Resting-State fMRI791 topic
- Deep Brain Stimulation701 topic
- Subthalamic Nucleus701 topic
Where does Jeffrey L. Cummings work?
Jeffrey L. Cummings's main affiliation in the publication record is Cleveland Clinic, United States.
How many publications and citations does Jeffrey L. Cummings have?
OpenAlex counts 1,499 works and 175,531 citations for Jeffrey L. Cummings, an h-index of 177, ranking #30,117 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jeffrey L. Cummings
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jeffrey L. Cummings. Posts are plain text and can be reported.